Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
October 12, 2010
Patent Application Number
11922467
Date Filed
June 28, 2006
Patent Primary Examiner
Patent abstract
Novel BRAFV600E mutant peptides or a pharmaceutically acceptable salt thereof, that induce MHC Class I-dependent cytotoxic T cell responses in mammals are useful in prophylactic, diagnostic and therapeutic treatments for melanoma. Such compounds are also useful in drug development for non-peptide mimics of the compounds described herein and in the development of therapeutic or diagnostic antibodies.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
